Patent ID: 7196104

Claim:
A compound of Formula VI wherein R 15 is one or more substituents selected from optionally substituted 5-membered heterocyclyloxy, optionally substituted heterocyclyl-C 1 –C 4 -alkoxy, C 1 –C 4 -alkylamino-C 1 –C 4 -alkoxy, and optionally substituted phenoxy, wherein R 16 is selected from H, alkylaminocarbonyl, and alkylaminomethyl; and wherein R 17 is selected from halo, C 1 –C 6 -alkyl, cycloalkylalkynyl, cycloalkyl, optionally substituted indolyl, optionally substituted indazolyl, optionally substituted phenoxy, unsubstituted 5-membered oxygen or sulfur containing heteroaryl, and phenyl optionally substituted with one or two substituents selected from halo, C 1 –C 4 -alkylamino, amino, nitro, C 1 –C 4 -alkoxy, C 1 –C 2 -haloalkyl, hydroxy, C 1 –C 4 -alkylthio, C 1 –C 4 -alkylcarbonylamino, (optionally substituted phenyl)sulfonylamino, cyano, C 1 –C 2 -haloalkoxy, 5- or 6-membered N-containing heterocyclyl, aminosulfonyl, (6-membered N-containing heterocyclyl)sulfonyl, C 1 –C 2 -haloalkylcarbonylaminosulfonyl and (optionally substituted phenyl)aminosulfonyl, and 6-membered nitrogen-containing heterocyclyl substituted with one or more substituents independently selected from pyridyl, phenyl, C 1 –C 4 alkyl, C 1 –C 2 haloalkyl, C 1 –C 2 alkoxy, amino, halo, piperidinyl, morpholinyl, C 1 –C 2 alkylpiperazinyl, C 1 –C 3 alkylaminothiocarbonyl, N,N-di-C 1 –C 2 -alkylamino-C 1 –C 4 -alkylenyl, N—C 1 –C 2 -alkylamino-C 1 –C 4 -alkylenyl, morpholinyl-C 1 –C 4 -alkylenylaminocarbonyl, aminocarbonyl, C 1 –C 2 -haloalkylcarbonylamino, morpholinyl-C 1 –C 4 -alkylenylamino, N,N-di-C 1 –C 2 -alkylamino and N,N-di-C 1 –C 2 -alkylamino-C 1 –C 4 -alkylenylamino; and pharmaceutically acceptable salts thereof.